Overview

Solar Oxygen Labs, an initiative under the Canadian non-profit social enterprise Innovative Canadians for Change (ICChange), addresses the global challenge of off-the-grid oxygen delivery. The project’s core innovation, Solaire One, is a self-sustaining medical system that integrates solar panels, battery banks, charge controllers, inverters, and medical concentrators. By converting free ambient sunlight and air into medical-grade oxygen, Solaire One provides continuous, 24/7 oxygen access to healthcare facilities operating in off-the-grid or low-resource settings.

The initiative operates on a localized, scalable implementation model. All hardware—including solar equipment and oxygen concentrators—is sourced locally through African energy vendors (e.g., Ultratec, SolarGen, Asrames) and medical suppliers. Solaire One systems are tailored to each facility based on local sunlight hours, grid reliability, and patient volume. Installation takes approximately one week per site using local electricians, supervised by team technicians who train local personnel to manage ongoing maintenance. To date, Solaire One has been deployed across 24 African hospitals—21 in Uganda, two in the Democratic Republic of the Congo, and one in Somalia—treating thousands of patients and establishing non-inferiority compared to conventional care methods.

The Systemic Problem

In low-resource settings globally, lack of reliable access to medical-grade oxygen is a major driver of preventable mortality. Clinical evidence indicates that reliable oxygen access can reduce childhood deaths from pneumonia by up to 35%. However, traditional oxygen supply chains are ill-suited for rural or underdeveloped regions.

Standard delivery methods depend heavily on high-pressure oxygen cylinders, which require robust transport supply chains for frequent refills, are logistically difficult to move, and demand complex handling. Alternatively, standard grid-powered oxygen concentrators fail frequently in these environments due to poor physical infrastructure and recurrent power outages. When power grids fluctuate or fail, clinics are left without oxygen, leading to preventable infant and pediatric deaths.

Outcomes

Through the deployment and clinical validation of Solaire One, Solar Oxygen Labs has achieved several outcomes:

• High Cost-Effectiveness: Solaire One delivers medical oxygen at $4.10 per 1,000 liters—48% cheaper than compressed oxygen cylinders. It saves life-years at a rate of $20 per disability-adjusted life year (DALY) saved (compared to $100 per DALY for vaccines like PCV), with every $542 invested directly saving a child’s life.
• Uninterrupted Reliability: Systems capture solar energy during daylight and store surplus power in specialized battery banks, securing continuous 24/7 oxygen therapy through nighttime hours, severe weather, or extended municipal blackout periods.
• Ease of Clinical Use: Operating the unit requires minimal nurse training. Following WHO pulse-oximetry guidelines, bedside clinical staff only need to power on the unit, attach the patient tubing, and adjust the flow rate dial.
• Sustainable Local Maintenance: Solaire One eliminates the need for external oxygen refills. Solar panels carry a 20-year lifespan, battery banks are swapped every 3–5 years, and internal filters are replaced monthly in-house. Technical maintenance (such as replacing gaskets or sieve beds every 6–12 months) costs approximately $100 per month and can be fully executed by local technicians without specialized external oversight.
• Scalable Implementation Framework: Solar Oxygen Labs established a standardized component and pricing structure (subtotaling approximately $9,755 USD per complete system setup), laying the groundwork for remote data monitoring and rapid partnership expansion across global markets.